ALIM's logo.
Ticker Symbol: ALIM

Alimera Sciences Inc.

$5.56 - 21-07-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001267602

Company Profile

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 6120 Windward Pkwy Ste 290
CEO: Richard Eiswirth
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing


Last Updated: October 20, 2023 03:30 PM EST
Previous Close: $3.05
Change: $0.02 ( 0.66%)
Days Range: $2.86 - $3.15
Beta: 0.84
52wk. High: $5.71
52wk. Low: $1.30
Ytd. Change 13.21%
50 Day Moving Average: $3.13
200 Day Moving Average: $2.84
Shares Outstanding: 8801727


Market Cap: 2.7B
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A